Annual Accounts Payable
$8.00 M
+$3.90 M+95.31%
September 30, 2024
Summary
- As of February 7, 2025, ENTA annual accounts payable is $8.00 million, with the most recent change of +$3.90 million (+95.31%) on September 30, 2024.
- During the last 3 years, ENTA annual accounts payable has fallen by -$1.54 million (-16.12%).
- ENTA annual accounts payable is now -16.12% below its all-time high of $9.54 million, reached on September 30, 2021.
Performance
ENTA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$8.00 M
-$2.67 M-25.04%
September 30, 2024
Summary
- As of February 7, 2025, ENTA quarterly accounts payable is $8.00 million, with the most recent change of -$2.67 million (-25.04%) on September 30, 2024.
- Over the past year, ENTA quarterly accounts payable has increased by +$3.90 million (+95.31%).
- ENTA quarterly accounts payable is now -31.96% below its all-time high of $11.76 million, reached on March 31, 2023.
Performance
ENTA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ENTA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +95.3% | +95.3% |
| 3 y3 years | -16.1% | -16.1% |
| 5 y5 years | +19.6% | -16.1% |
ENTA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.1% | +95.3% | -32.0% | +542.7% |
| 5 y | 5-year | -16.1% | +95.3% | -32.0% | +542.7% |
| alltime | all time | -16.1% | +1313.8% | -32.0% | +1313.8% |
Enanta Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $8.00 M(+95.3%) | $8.00 M(-25.0%) |
| Jun 2024 | - | $10.68 M(+58.7%) |
| Mar 2024 | - | $6.73 M(-27.9%) |
| Dec 2023 | - | $9.33 M(+127.6%) |
| Sep 2023 | $4.10 M(-31.7%) | $4.10 M(-48.3%) |
| Jun 2023 | - | $7.93 M(-32.6%) |
| Mar 2023 | - | $11.76 M(+170.2%) |
| Dec 2022 | - | $4.35 M(-27.5%) |
| Sep 2022 | $6.00 M(-37.1%) | $6.00 M(+381.9%) |
| Jun 2022 | - | $1.25 M(-79.2%) |
| Mar 2022 | - | $5.99 M(-23.7%) |
| Dec 2021 | - | $7.84 M(-17.8%) |
| Sep 2021 | $9.54 M(+66.3%) | $9.54 M(+61.8%) |
| Jun 2021 | - | $5.89 M(+3.4%) |
| Mar 2021 | - | $5.70 M(-9.6%) |
| Dec 2020 | - | $6.30 M(+9.9%) |
| Sep 2020 | $5.74 M(-14.2%) | $5.74 M(-5.5%) |
| Jun 2020 | - | $6.07 M(+2.2%) |
| Mar 2020 | - | $5.95 M(-9.9%) |
| Dec 2019 | - | $6.60 M(-1.4%) |
| Sep 2019 | $6.69 M(+41.0%) | $6.69 M(+2.8%) |
| Jun 2019 | - | $6.50 M(-26.8%) |
| Mar 2019 | - | $8.88 M(+58.0%) |
| Dec 2018 | - | $5.62 M(+18.5%) |
| Sep 2018 | $4.75 M | $4.75 M(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $4.90 M(+4.4%) |
| Mar 2018 | - | $4.70 M(+43.7%) |
| Dec 2017 | - | $3.27 M(-12.0%) |
| Sep 2017 | $3.71 M(+10.0%) | $3.71 M(-32.3%) |
| Jun 2017 | - | $5.49 M(+35.3%) |
| Mar 2017 | - | $4.06 M(+107.8%) |
| Dec 2016 | - | $1.95 M(-42.2%) |
| Sep 2016 | $3.38 M(+118.9%) | $3.38 M(+65.2%) |
| Jun 2016 | - | $2.04 M(-20.5%) |
| Mar 2016 | - | $2.57 M(-7.0%) |
| Dec 2015 | - | $2.77 M(+79.3%) |
| Sep 2015 | $1.54 M(-17.7%) | $1.54 M(-4.4%) |
| Jun 2015 | - | $1.61 M(-31.1%) |
| Mar 2015 | - | $2.34 M(+313.2%) |
| Dec 2014 | - | $567.00 K(-69.7%) |
| Sep 2014 | $1.87 M(+26.5%) | $1.87 M(+46.0%) |
| Jun 2014 | - | $1.28 M(-37.1%) |
| Mar 2014 | - | $2.04 M(+143.0%) |
| Dec 2013 | - | $840.00 K(-43.3%) |
| Sep 2013 | $1.48 M(-20.0%) | $1.48 M(+61.3%) |
| Jun 2013 | - | $918.00 K(-61.3%) |
| Mar 2013 | - | $2.37 M(+33.7%) |
| Dec 2012 | - | $1.77 M(-4.2%) |
| Sep 2012 | $1.85 M(+227.0%) | $1.85 M(+122.2%) |
| Jun 2012 | - | $833.00 K(+47.2%) |
| Sep 2011 | $566.00 K | $566.00 K |
FAQ
- What is Enanta Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual accounts payable year-on-year change?
- What is Enanta Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly accounts payable year-on-year change?
What is Enanta Pharmaceuticals annual accounts payable?
The current annual accounts payable of ENTA is $8.00 M
What is the all time high annual accounts payable for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual accounts payable is $9.54 M
What is Enanta Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, ENTA annual accounts payable has changed by +$3.90 M (+95.31%)
What is Enanta Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ENTA is $8.00 M
What is the all time high quarterly accounts payable for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly accounts payable is $11.76 M
What is Enanta Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, ENTA quarterly accounts payable has changed by +$3.90 M (+95.31%)